Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults

Nutrition

Volumn 30, Issue 6, 2014, Pages 636-644

  Haghighatdoost, Fahimeh ^a,b   Sarrafzadegan, Nizal ^c   Mohammadifard, Noushin ^c   Asgary, Sedigheh ^c   Boshtam, Maryam ^c   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

A body shape index; Cardiovascular risks; Clinica Universidad de Navarra Body Adiposity Estimator; Metabolic syndrome; Waist to height ratio

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY BUILD; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IRANIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST TO HEIGHT RATIO; ABDOMINAL OBESITY; ADOLESCENT; AGED; AREA UNDER THE CURVE; BLOOD; BLOOD PRESSURE; BODY SIZE; CARDIOVASCULAR DISEASES; COMPLICATION; EPIDEMIOLOGY; IRAN; MIDDLE AGED; OBESITY; PHYSIOLOGY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BODY SIZE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; WAIST-HEIGHT RATIO; YOUNG ADULT;

EID: 84899739998     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.10.021     Document Type: Article

References (52)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Hansson G.K. Inflammation, atherosclerosis & coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Ghassemi H., Harrison G., Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 2002, 5:149-155.
4. Accessed April 13,2013. http://www.emro.who.int/health-topics/cardiovascular-diseases/.
5. Sarraf-Zadegan N., Boshtam M., Malekafzali H., et al. Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. ActaCardiol 1999, 54:327-333.
6. Azizi F., Salehi P., Etemadi A., Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res ClinPract 2003, 61:29-37.
7. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993, 44:121-131.
8. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
9. Seo D.C., Niu J. Trends in underweight and overweight/obesity prevalence in Chinese youth, 2004-2009. Int J Behav Med 2013, [Epub ahead of print].
10. Ogden C.L., Carroll M.D., Cutin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in United States, 1999 to 2004. JAMA 2006, 295:1549-1555.
11. Azadbakht L., Mirmiran P., Shiva N., Azizi F. General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res 2005, 75:297-304.
12. Janssen I., Katzmarzyk P.T., Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004, 79:379-384.
13. Pajunen P., Jousilahti P., Borodulin K., Harald K., Tuomilehto J., Salomaa V. Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK'92 cohort. Obesity (Silver Spring) 2011, 19:848-852.
14. Nevill A.M., Stewart A.D., Olds T., Holder R. Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol 2006, 129:151-156.
15. Heymsfield S.B., Scherzer R., Pietrobelli A., Lewis C.E., Grunfeld C. Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample. Int J Obes (Lond) 2009, 33:1363-1373.
16. Kang S.M., Yoon J.W., Ahn H.Y., Kim S.Y., Lee K.H., Shin H., et al. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PLoS One 2011, 6:e27694.
17. Manolopoulos K.N., Karpe F., Frayn K.N. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010, 34:949-959.
18. Esmaillzadeh A., Mirmiran P., Moeini S.H., Azizi F. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol 2006, 108:338-345.
19. Bigaard J., Frederiksen K., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., et al. Body fat and fat-free mass and all-cause mortality. Obesity 2004, 12:1042-1049.
20. Zhu S., Wang Z., Heshka S., Heo M., Faith M.S., Heymsfield S.B. Waist circumference and obesity-associated risk factors among whites in the NHANES III: clinical action thresholds. Am J Clin Nutr 2002, 76:743-749.
21. Hsieh S.D., Yoshinaga H., Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003, 27:610-616.
22. Browning L.M., Hsieh S.D., Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010, 23:247-269.
23. Ashwell M., Gunn P., Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012, 13:275-286.
24. Langenberg C., Shipley M.J., Batty G.D., Marmot M.G. Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health 2005, 95:628-632.
25. Esmaillzadeh A., Mirmiran P., Azizi F. Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women. Public Health Nutr 2006, 9:61-69.
26. Guasch-Ferré M., Bulló M., Martínez-González M.Á., Corella D., Estruch R., Covas M.I., et al. Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk. PLoS One 2012, 7:e43275.
27. Gómez-Ambrosi J., Silva C., Catalán V., Rodríguez A., Galofré J.C., Escalada J., et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care 2012, 35:383-388.
28. Krakauer N.Y., Krakauer J.C. A new body shape index predicts mortality hazard independently of body mass index. PLoS One 2012, 7:e39504.
29. Sarraf-Zadegan N., Sadri G.H., Malek Afzali H., Baghaei M., Mohamadi Fard N., Shahrokhi S., et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiologica 2003, 58:309-320.
30. Sarraf-Zadegan N., Baghaei A.M., Sadri G.H., Kelishadi R., Malekafzali H., Boshtam M., et al. Isfahan Healthy Heart Program: evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prev Control 2006, 2:73-84.
31. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. a consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
32. Delavari A., Forouzanfar M.H., Alikhani S., Sharifian A., Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009, 32:1092-1097.
33. McNamara J.R., Schaefer E.J. Automated enzymatic standardized lipid analyses for plasma and lipid lipoprotein fractions. Clin Chem Acta 1987, 166:1-8.
34. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-magnesium precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem 1982, 28:1379-1382.
35. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
36. Khuseyinova N., Imhof A., Trischler G., Rothenbacher D., Hutchinson W.L., Pepys M.B., et al. Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. Clin Chem 2003, 49:1691-1695.
37. Weitzman S., Wang C.H., Pankow J.S., Schmidt M.I., Brancati F.L. Are measures of height and leg length related to incident diabetes mellitus? The ARIC (Atherosclerosis Risk in Communities) study. Acta Diabetol 2010, 47:237-242.
38. Smith L.G., Yatsuya H., Psaty B.M., Longstreth W.T., Folsom A.R. Height and risk of incident intraparenchymal hemorrhage: atherosclerosis risk in communities and cardiovascular health study cohorts. J Stroke Cerebrovasc Dis 2013, 22:323-328.
39. Gunnell D. Commentary: early insights into height, leg length, proportionate growth and health. Int J Epidemiol 2001, 30:221-222.
40. Lean M.E., Han T.S., Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr 1996, 63:4-14.
41. Bosy-Westphal A., Geisler C., Onur S., Korth O., Selburg O., Schrezenmeir J., et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) 2006, 30:475-483.
42. Siavash M., Sadeghi M., Salarifar F., Amini M., Shojaee-Moradie F. Comparison of body mass index and waist/height ratio in predicting definite coronary artery disease. Ann Nutr Metab 2008, 53:162-166.
43. Heidari-Beni M., Hajimaghsood M., Ebrahimi-Mamaghani M., Jafarabadi M.A., Mousavi-Jazayeri S.M., Mohtadinia J. Diagnostic value of anthropometric indices for initial stage of atherosclerosis in adult women. Asia Pac J Clin Nutr 2012, 21:220-226.
44. Esmaillzadeh A., Mirmiran P., Azizi F. Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes Relat Metab Disord 2004, 28:1325-1332.
45. Li W.C., Chen I.C., Chang Y.C., Loke S.S., Wang S.H., Hsiao K.Y. Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. Eur J Nutr 2013, 52:57-65.
46. Park Y.S., Kim J.S. Association between waist-to-height ratio and metabolic risk factors in Korean adults with normal body mass index and waist circumference. Tohoku J Exp Med 2012, 22:1-8.
47. Ashwell M., Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet And Nutrition Survey of adults aged 19 to 64 years. Obes Facts 2009, 2:97-103.
48. Molarius A., Seidell J.C. Selection of anthropometric indicators for classification of abdominal fatness-critical review. Int J Obes Relat Metab Disord 1998, 22:719-727.
49. Foucan L., Hanley J., Deloumeaux J., Suissa S. Body mass index and waist circumference as screening tools for cardiovascular risk factors in Guadeloupian women. J Clin Epidemiol 2002, 55:990-996.
50. Lear S.A., Chen M.M., Frohlich J.J., Birmingham C.L. The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism 2002, 51:1427-1432.
51. Gallagher D., Visser M., Sepulueda D., Pierson R.N., Harris T., Heymsfield S.B. How useful is body mass index for comparison of body fatness across age, sex and ethnic groups. Am J Epidemiol 1996, 143:228-239.
52. Azadbakht L., Esmaillzadeh A. Dietary and non-dietary determinants of central adiposity among Tehrani women. Public Health Nutr 2008, 11:528-534.